Harvard Bioscience: Harvard Bioscience, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024

Harvard Bioscience, Inc. reported earnings results for the fourth quarter and full year ended December 31, 2024. For the fourth quarter, the company reported sales was USD 24.56 million compared to USD 28.15 million a year ago. Net income was USD 0.018 million compared to net loss of USD 1.82 million a year ago. For the full year, sales was USD 94.14 million compared to USD 112.25 million a year ago. Net loss was USD 12.41 million compared to USD 3.42 million a year ago. Basic loss per share from continuing operations was USD 0.28 compared to USD 0.08 a year ago. Diluted loss per share from continuing operations was USD 0.28 compared to USD 0.08 a year ago.